EW
CORZ

Evoke Wealth’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Evoke Wealth’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-25,000
Closed -$33K – 1229
2022
Q3 		$33K Hold
25,000
– – ﹤0.01% 576
2022
Q2 		$37K Hold
25,000
– – ﹤0.01% 557
2022
Q1 		$206K Hold
25,000
– – 0.01% 349
2021
Q4 		$274K Hold
25,000
– – 0.01% 323
2021
Q3 		$252K Buy
+25,000
New +$251K 0.01% 306

Other funds holding CORZ

PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
STA
Summit Trail Advisors New York $6.98B AUM 19.51% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Evoke Wealth's CORZ Position: Q4 2022 in Review

Evoke Wealth sold out of Core Scientific, Inc. Common Stock (CORZ) in Q4 2022, closing a stake of 25,000 shares — an estimated $33K sold.

Evoke Wealth first reported a position in CORZ in Q3 2021 and held it in 5 quarters. The position peaked at $274K in Q4 2021. 89 funds tracked by Wall St. Rank hold CORZ as of Q4 2022.

  • Evoke Wealth reported no remaining Core Scientific, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Evoke Wealth sold 25,000 Core Scientific, Inc. Common Stock shares in Q4 2022, an estimated $33K.
  • Evoke Wealth first reported a position in Core Scientific, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Evoke Wealth's Core Scientific, Inc. Common Stock position peaked at $274K in Q4 2021.
  • 89 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.